2'-deoxyadenosine triphosphate has been researched along with Heart Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Moussavi-Harami, F; Racca, AW; Razumova, MV; Regnier, M; Stempien-Otero, A | 1 |
| Carey, J; Kadota, S; Laflamme, MA; Leggett, J; Mahairas, GG; Murry, CE; Regnier, M; Reinecke, H; Teichman, S | 1 |
| Regnier, M; Teichman, SL; Thomson, KS | 1 |
1 review(s) available for 2'-deoxyadenosine triphosphate and Heart Failure
| Article | Year |
|---|---|
Cardiac Myosin Activation with Gene Therapy Produces Sustained Inotropic Effects and May Treat Heart Failure with Reduced Ejection Fraction.
Topics: Animals; Cardiac Myosins; Deoxyadenine Nucleotides; Genetic Therapy; Heart Failure; Humans; Myocardial Contraction; Myocardium; Stroke Volume | 2017 |
2 other study(ies) available for 2'-deoxyadenosine triphosphate and Heart Failure
| Article | Year |
|---|---|
2-Deoxy adenosine triphosphate improves contraction in human end-stage heart failure.
Topics: Adult; Demography; Deoxyadenine Nucleotides; Female; Heart Failure; Humans; Isometric Contraction; Male; Middle Aged; Myocardial Contraction; Myofibrils; Nucleoside-Triphosphatase; Vasodilation | 2015 |
Ribonucleotide reductase-mediated increase in dATP improves cardiac performance via myosin activation in a large animal model of heart failure.
Topics: Animals; Blood Pressure; Chronic Disease; Deoxyadenine Nucleotides; Dependovirus; Disease Models, Animal; Echocardiography; Genetic Therapy; Genetic Vectors; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Myocardial Infarction; Pilot Projects; Ribonucleotide Reductases; Swine; Swine, Miniature; Systole | 2015 |